Cargando…
Available and emerging treatments for Parkinson’s disease: a review
Parkinson’s disease is a commonly encountered neurodegenerative disorder primarily found in aged populations. A number of medications are available to control symptoms, although these are less effective in advanced disease. Deep brain stimulation provides a practicable alternative at this stage, alt...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096539/ https://www.ncbi.nlm.nih.gov/pubmed/21607020 http://dx.doi.org/10.2147/DDDT.S11836 |
_version_ | 1782203723676647424 |
---|---|
author | Hickey, Patrick Stacy, Mark |
author_facet | Hickey, Patrick Stacy, Mark |
author_sort | Hickey, Patrick |
collection | PubMed |
description | Parkinson’s disease is a commonly encountered neurodegenerative disorder primarily found in aged populations. A number of medications are available to control symptoms, although these are less effective in advanced disease. Deep brain stimulation provides a practicable alternative at this stage, although a minority of patients meet the strict criteria for surgery. Novel medications that provide enhanced symptomatic control remain in developmental demand. Both gene and cell-based therapies have shown promise in early clinical studies. A major unmet need is a treatment that slows or stops disease progression. |
format | Text |
id | pubmed-3096539 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-30965392011-05-23 Available and emerging treatments for Parkinson’s disease: a review Hickey, Patrick Stacy, Mark Drug Des Devel Ther Review Parkinson’s disease is a commonly encountered neurodegenerative disorder primarily found in aged populations. A number of medications are available to control symptoms, although these are less effective in advanced disease. Deep brain stimulation provides a practicable alternative at this stage, although a minority of patients meet the strict criteria for surgery. Novel medications that provide enhanced symptomatic control remain in developmental demand. Both gene and cell-based therapies have shown promise in early clinical studies. A major unmet need is a treatment that slows or stops disease progression. Dove Medical Press 2011-05-02 /pmc/articles/PMC3096539/ /pubmed/21607020 http://dx.doi.org/10.2147/DDDT.S11836 Text en © 2011 Hickey and Stacy, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. |
spellingShingle | Review Hickey, Patrick Stacy, Mark Available and emerging treatments for Parkinson’s disease: a review |
title | Available and emerging treatments for Parkinson’s disease: a review |
title_full | Available and emerging treatments for Parkinson’s disease: a review |
title_fullStr | Available and emerging treatments for Parkinson’s disease: a review |
title_full_unstemmed | Available and emerging treatments for Parkinson’s disease: a review |
title_short | Available and emerging treatments for Parkinson’s disease: a review |
title_sort | available and emerging treatments for parkinson’s disease: a review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096539/ https://www.ncbi.nlm.nih.gov/pubmed/21607020 http://dx.doi.org/10.2147/DDDT.S11836 |
work_keys_str_mv | AT hickeypatrick availableandemergingtreatmentsforparkinsonsdiseaseareview AT stacymark availableandemergingtreatmentsforparkinsonsdiseaseareview |